Pharmacological Characterization of the Receptor Mediating the Anorexigenic Action of the Octadecaneuropeptide: Evidence for an Endozepinergic Tone Regulating Food Intake

[1]  H. Vaudry,et al.  CHAPTER 111 – Endozepines , 2006 .

[2]  A. Kastin.  Handbook of biologically active peptides , 2006 .

[3]  H. Vaudry,et al.  In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat. , 2005, Brain research. Molecular brain research.

[4]  H. Vaudry,et al.  In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain , 2004, Neuroscience.

[5]  L. Pieri,et al.  Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects , 2004, Psychopharmacology.

[6]  H. Vaudry,et al.  Effect of Intracerebroventricular Administration of the Octadecaneuropeptide on the Expression of Pro‐Opiomelanocortin, Neuropeptide Y and Corticotropin‐Releasing Hormone mRNAs in Rat Hypothalamus , 2003, Journal of neuroendocrinology.

[7]  T. Iwanaga,et al.  Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein. , 2002, Archives of histology and cytology.

[8]  H. Vaudry,et al.  Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. , 2001, European journal of biochemistry.

[9]  H. Vaudry,et al.  The triakontatetraneuropeptide TTN increases [Ca2+]i in rat astrocytes through activation of peripheral‐type benzodiazepine receptors , 2001, Glia.

[10]  H. Vaudry,et al.  The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. , 2001, European journal of pharmacology.

[11]  H. Vaudry,et al.  Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN☆ , 1999, Peptides.

[12]  H. Vaudry,et al.  Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. , 1998, Journal of medicinal chemistry.

[13]  H. Vaudry,et al.  The octadecaneuropeptide ODN inhibits apomorphine-induced yawning in rats. , 1998, European journal of pharmacology.

[14]  H. Vaudry,et al.  The Octadecaneuropeptide ODN Induces Anxiety in Rodents: Possible Involvement of a Shorter Biologically Active Fragment , 1998, Peptides.

[15]  H. Vaudry,et al.  The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. , 1997, European journal of pharmacology.

[16]  H. Vaudry,et al.  The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes , 1995, FEBS letters.

[17]  H. Vaudry,et al.  Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain , 1993, Neuroscience.

[18]  L. Cazin,et al.  Allosteric Modulation of the GABA‐Induced Chloride Current in Frog Melanotrophs a , 1993, Annals of the New York Academy of Sciences.

[19]  J. Bormann.  Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptors , 1991, Neuropharmacology.

[20]  G. Pelletier,et al.  Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization , 1991, Neuropeptides.

[21]  G. Biggio,et al.  Gaba and Benzodiazepine Receptor Subtypes , 1991 .

[22]  A. Guidotti,et al.  A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes. , 1990, Molecular pharmacology.

[23]  H. Vaudry,et al.  Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain , 1990, Neuropeptides.

[24]  P. Bovolin,et al.  The endogenous allosteric modulation of GABAA receptor subtypes: a role for the neuronal posttranslational processing products of rat brain DBI. , 1990, Advances in biochemical psychopharmacology.

[25]  L. Cazin,et al.  Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of α-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro , 1989, Neuroscience.

[26]  A. Guidotti,et al.  Isolation and Characterization of a Rat Brain Triakontatetraneuropeptide, a Posttranslational Product of Diazepam Binding Inhibitor: Specific Action at the Ro 5‐4864 Recognition Site , 1989, Journal of neurochemistry.

[27]  E. Costa,et al.  Allosteric modulation of amino acid receptors : therapeutic implications , 1989 .

[28]  E. Costa,et al.  Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Santi,et al.  Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Guidotti,et al.  Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. , 1985, Science.

[31]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Le Fur,et al.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. , 1983, Life sciences.

[33]  J. Bénavidès,et al.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. , 1983, Life sciences.

[34]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.